Lv42
528 积分 2022-12-20 加入
Induction chemotherapy and molecular MRD influence outcomes in KMT2A -rearranged AML
1个月前
已关闭
Immunochemotherapy for life-threatening haematological malignancies in pregnancy: a systematic review of the literature and cross-sectional analysis of clinical trial eligibility
1个月前
已关闭
Chidamide maintenance therapy after allo-HSCT in SET-NUP214 fusion positive T-ALL patients: A report of two cases
4个月前
已完结
Effects of post-transplant maintenance therapy with decitabine prophylaxis on the relapse for acute lymphoblastic leukemia
4个月前
已完结
Comparative analysis of hypomethylating agents as maintenance therapy after allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia
4个月前
已完结
Sequential treatment with PARPi and WEE1i enhances antitumor immune responses in preclinical models of ovarian cancer
4个月前
已完结
Immunomodulatory effect of dasatinib plus blinatumomab versus ponatinib plus blinatumomab in newly diagnosed Ph+ acute lymphoblastic leukemia
4个月前
已完结
Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT
4个月前
已完结
Prognosis of patients with acute lymphoblastic leukaemia relapsing after allogeneic stem cell transplantation
4个月前
已完结
Bridging With Chimeric Antigen Receptor T‐Cell Therapy or Chemotherapy to Allo‐ HSCT in B‐ ALL : A Comparison of Treatment Complications and Survival
6个月前
已完结
皖公网安备34019202002308
